AbbVie ABBV has successfully navigated the loss of exclusivity (LOE) for its flagship drug, Humira, by launching two newer ...

As a writer, I often stare into oblivion, hoping that some idea comes flying out of the blue, penetrates my mind and speaks: “This is it! The Jackpot! You’re really gonna knock ‘em dead with this one!

Three Motley Fool contributors think they've found ideal dividend growth stocks to buy and hold -- and all three are ...

The author includes U.S. and Canadian names, organized by country. Each company comes with a business summary, plus a bull ...

Upadacitinib 15 mg — but not 7.5 mg — alongside a glucocorticoid taper demonstrated superior efficacy to placebo with a ...

Leonard Calabrese, DO, Paras Karmacharya, MD, MS, and Adam Kilian, MD, explore how the older average age of patients with GCA ...

As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy ...

AbbVie will also acquire Capstan’s CellSeeker tLNP platform technology, which is designed to deliver RNA payloads, such as ...